Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.71 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.71 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.71 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.71 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.69 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.63 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.63 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.63 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.63 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.63 |
| ▸ | CES2 | O00748 | 1/20 | 0.63 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.63 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.63 |
| ▸ | DGKA | P23743 | 1/20 | 0.63 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | SELP | P16109 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8002666 | 0.99 | PRKCA (0.73) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL2126223 | 0.99 | PRKCA (0.73) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL8911249 | 0.99 | PRKCA (0.73) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| Glycerin SCHEMBL28136461 | 0.94 | DGKA (0.70) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL30668211 | 0.92 | ENPP2 (0.75) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL2125352 | 0.92 | FAAH (0.66) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL8911157 | 0.91 | PRKCA (0.68) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL8910338 | 0.91 | PRKCA (0.68) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL19433866 | 0.91 | PRKCA (0.68) | PRKCAPRKCEPRKCQPRKCDENPP2 | |
| SCHEMBL8910329 | 0.91 | PRKCA (0.68) | PRKCAPRKCEPRKCQPRKCDENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1007 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033849-A1 | CBD SUNSCREEN FORMULATIONS AND USES THEREOF | JUPITER WELLNESS INC (US) | 2023-02-02 | — | — | US | claimed |
| EP-2501777-B1 | BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX | GRUNE GUERRY L (US) | 2022-10-26 | — | — | EP | claimed |
| US-20190099342-A1 | COOLING PRODUCT | SYMRISE AG (DE) | 2019-04-04 | — | — | US | claimed |
| US-8858922-B2 | Broad spectrum UVA stable, non-toxic, zinc oxide based complex | 3rd Rock Sunblock, Inc. (US) | 2014-10-14 | — | — | US | claimed |
| US-8465729-B2 | Sunscreen compositions with SPF enhancer | PLAYTEX PRODUCTS, INC. (US) | 2013-06-18 | — | — | US | claimed |
| EP-2252253-B1 | PHOTOPROTECTIVE COMPOSITIONS WITH GLYCOL AND STYRENE/ACRYLATE COPOLYMER | PLAYTEX PRODUCTS LLC (US) | 2013-05-01 | — | — | EP | claimed |
| US-20120263661-A1 | Broad Spectrum UVA Stable, Non-Toxic, Zinc Oxide Based Complex | GRUNE GUERRY L (US) | 2012-10-18 | — | — | US | claimed |
| EP-1805560-B1 | METHOD OF PREVENTING PREMATURE CURING OF CUT SURFACES OF A PHOTOSENSITIVE PRINTING ELEMENT, PHOTOSENSITIVE PRINTING ELEMENT OBTAINABLE BY SUCH A METHOD | MACDERMID PRINTING SOLUTIONS (US) | 2012-10-03 | — | — | EP | claimed |
| EP-2501777-A2 | BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX | Grune, Guerry L. (US) | 2012-09-26 | — | — | EP | claimed |
| EP-2478890-A1 | Photoprotective compositions with caprylyl glycol and styrene/acrylate copolymer | Playtex Products, Llc (US) | 2012-07-25 | — | — | EP | claimed |
| WO-2004100914-A2 | SUNSCREEN OR MEDICINAL WIPES HAVING HIGH SUNSCREEN FORMULATION TRANSFER RATE | KIMBERLY-CLARK WORLDWIDE INC. (US) | 2004-11-25 | — | — | WO | claimed |
| US-20040228811-A1 | Sunscreen wipes having high sunscreen formulation transfer rate | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-11-18 | — | — | US | claimed |
| US-20040028709-A1 | Sunscreen compositions | PLAYTEX PRODUCTS, INC. | 2004-02-12 | — | — | US | claimed |
| WO-2003103615-A1 | SUNSCREEN COMPOSITIONS | PLAYTEX PRODUCTS, INC. (US) | 2003-12-18 | — | — | WO | claimed |
| WO-2003026595-A1 | SUNSCREEN COMPOSITIONS | PLAYTEX PRODUCTS, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| US-20030059383-A1 | Sunscreen compositions | PLAYTEX PRODUCTS, INC. | 2003-03-27 | — | — | US | claimed |
| EP-1047369-A2 | EMULSIONS HAVING MINIMAL RUB-IN TIMES | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 2000-11-02 | — | — | EP | claimed |
| US-5916543-A | CONSISTS OF A NONAQUEOUS PHASE, AN AQUEOUS PHASE CONTAINING DIHYDROXYACETONE, AN OIL-IN WATER EMULSIFYING AGENT COMPRISING POLYOXYPROPYLENE GLYCOL-1-TRIDECETH-6, PROPYLENE GYCOL DICARPRYLATE DICAPRATE, POLYQUATERNIUM 37 | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1999-06-29 | — | — | US | claimed |
| WO-1998027934-A2 | EMULSIONS HAVING MINIMAL RUB-IN TIMES | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1998-07-02 | — | — | WO | claimed |
| US-5047232-A | Sunscreen agent with water in oil emulsifier | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-09-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190099342-A1 | COOLING PRODUCT | TRPA1, TRPV2, NISCH | PRKCA 1046/4885PRKCE 2339/4885PRKCQ 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.